Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-20 | Checkpoint Therapeutics, Inc. | Fortress Biotech,...
(AtLeastTenPercentOwner) |
A | COMMON STOCK, PAR VALUE $0.0001 | A | 193905 | $0.00 - $0.00 | $0 |
| 2024-02-28 | Checkpoint Therapeutics, Inc. | Oliviero James F III
(CEO, President and Director) |
S | COMMON STOCK | D | 5894 | $2.06 - $2.06 | $12,141 |
| 2024-02-28 | Checkpoint Therapeutics, Inc. | Oliviero James F III
(CEO, President and Director) |
G | COMMON STOCK | D | 9056 | $0.00 - $0.00 | $0 |
| 2024-02-28 | Checkpoint Therapeutics, Inc. | GRAY WILLIAM GARRETT
(Chief Financial Officer) |
S | Common Stock | D | 2035 | $2.07 - $2.07 | $4,212 |
| 2024-02-01 | Checkpoint Therapeutics, Inc. | GRAY WILLIAM GARRETT
(Chief Financial Officer) |
S | Common Stock | D | 4115 | $1.95 - $1.95 | $8,024 |
| 2024-02-01 | Checkpoint Therapeutics, Inc. | Oliviero James F III
(CEO, President and Director) |
S | COMMON STOCK | D | 11900 | $2.01 - $2.01 | $23,918 |
| 2024-02-01 | Checkpoint Therapeutics, Inc. | Oliviero James F III
(CEO, President and Director) |
G | COMMON STOCK | D | 12950 | $0.00 - $0.00 | $0 |
| 2023-02-24 | Checkpoint Therapeutics, Inc. | Oliviero James F III
(CEO, President and Director) |
G | Common Stock | D | 54510 | $0.00 - $0.00 | $0 |
| 2023-12-29 | Checkpoint Therapeutics, Inc. | Fortress Biotech,...
(AtLeastTenPercentOwner) |
A | COMMON STOCK, PAR VALUE $0.0001 | A | 158134 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |